Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic use of nuclear beta-catenin expression for the assessment of endometrial stromal tumors.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Jun 2008

Jung Chan-Kwon, Jung Ji-Han, Lee Ahwon, Lee Youn-Soo, Choi Yeong-Jin, Yoon Seung-Kew, Lee Kyo-Young

Abstract excerpt

Alterations in beta-catenin degradation cause it to accumulate to immunohistochemically detectable levels in the nuclei of tumor cells. Although it has been shown that nuclear beta-catenin immunostaining is useful for the diagnosis of some mesenchymal tumors, there is little known about beta-catenin expression in endometrial stromal tumors. In this study, nuclear beta-catenin immunoreactivity was evaluated in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Nucleus

Share to Diagnosis, Differential

Share to Immunohistochemistry

Share to Leiomyoma

Share to Neprilysin

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 18376386
DOI: 10.1038/modpathol.2008.53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic use of nuclear beta-catenin expression for the assessment of endometrial stromal tumors.PMID 18376386Read ↗

Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association.Semantic proximity Read ↗

Coincident expression of beta-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas.Semantic proximity Read ↗

Lymphoid Enhancer-Binding Factor 1 (LEF1) immunostaining as a surrogate of β-catenin (<i>CTNNB1)</i>mutationsSemantic proximity Read ↗

Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial CancerSemantic proximity Read ↗

β-catenin is a potential prognostic biomarker in uterine sarcomaSemantic proximity Read ↗

CTNNB1 mutation represents a recurrent driver molecular alteration in a subset of endometrial stromal tumors.Semantic proximity Read ↗

Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid CarcinomaSemantic proximity Read ↗

beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.Semantic proximity Read ↗

High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary.Semantic proximity Read ↗

CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome.Semantic proximity Read ↗

Endometrial Adenocarcinomas With No Specific Molecular Profile: Morphologic Features and Molecular Alterations of "Copy-number Low" Tumors.Semantic proximity Read ↗

Differential Localization of β-Catenin Protein in CTNNB1 Mutant Endometrial Cancers Results in Distinct Transcriptional Profiles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.